Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC447

Mavacamten eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    4.12.2023
  • Application published:
    15.1.2024
  • Grant published:
    15.11.2025
  • Max expiry date:
    25.6.2038
  • Medicine name:
    Camzyos
  • Medicine for children:
    No

Timeline

Today
4.12.2023Application
15.1.2024Publication
15.11.2025Registration
25.6.2038Expires

Marketing license

  • IS authorization number:
    EU/1/23/1716
  • Date:
    9.8.2023
  • Foreign authorization number:
    EU/1/23/1716
  • Date:
    26.6.2023

Owner

  • Name:
    MyoKardia, Inc.
  • Address:
    1000 Sierra Point Parkway, Brisbane, CA 94005 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 10.10.2025

Upload documents